The rationale and design of the national familial hypercholesterolemia registries in Turkey: A-HIT1 and A-HIT2 studies

https://phgkb.cdc.gov/GAPPKB/phgHome.do




Last Posted: May 18, 2017

---

• The rationale and design of the national familial hypercholesterolemia registries in Turkey: A-HIT1 and A-HIT2 studies.  
  Kayikçioglu Meral et al. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 2017 Apr 45(3) 261-267
• Transitioning from pediatric to adult health care with familial hypercholesterolemia: Listening to young adult and parent voices.  
  Sliwinski Samantha K et al. Journal of clinical lipidology 11(1) 147-159
• New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials.  
  Ellis Katrina L et al. European journal of preventive cardiology 2017 Jan 2047487317708890
• Can we afford not to screen for FH?  
  RM Stoekenbroek et al, Europ Heart Journal, April 2017
• Nine paths to PCSK9 inhibition  
  A Mullard, Nature Rev Drug Discovery, April 2017
• I Never Had a Clue  
  the FH Foundation, April 24, 2017
• International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next?  
  Pang Jing et al. Journal of atherosclerosis and thrombosis 2016 May 23(5) 505-19
• Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world?  
  Nordestgaard Børge G et al. European heart journal 2017 Apr
• Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.  
  Carroll Christopher et al. PharmacoEconomics 2017 May (5) 537-547
• Genetic Architecture of Familial Hypercholesterolaemia  
  M Sharifi et al, Curr Cardio Reports, May 2017
• Clinical and molecular aspects of familial hypercholesterolemia in Ibero-American countries.  
  Santos Raul D et al. Journal of clinical lipidology 11(1) 160-166
• Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia.  
  Lázaro Pablo et al. Journal of clinical lipidology 11(1) 260-271
• Familial hypercholesterolemia in the Czech Republic: more than 17 years of systematic screening within the MedPed project.  
  Vrablík M et al. Physiological research 2017 Apr 66(Supplementum 1) S1-S9
• Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK.  
  Kerr Marion et al. European heart journal 2017 Apr
• Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC).  
  Futema Marta et al. Atherosclerosis 2017 Mar 26047-55
• Design of the Familial Hypercholesterolaemia Australasia Network Registry: Creating Opportunities for Greater International Collaboration.  
  Bellgard Matthew I et al. Journal of atherosclerosis and thrombosis 2017 Mar

more